Citation Impact
Citing Papers
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease
2012
Microbiota in health and diseases
2022 Standout
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements
2012
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity
2020
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
2012
From NASH to HCC: current concepts and future challenges
2019
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
2016
IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity
2022
Disease Modeling and Gene Therapy of Copper Storage Disease in Canine Hepatic Organoids
2015
Macrophage Polarization: Implications on Metabolic Diseases and the Role of Exercise
2016
Mechanisms of hepatic stellate cell activation
2017 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
Interaction Between Obesity and the Gut Microbiota: Relevance in Nutrition
2011
Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway
2016
Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes
2015
The changing landscape of atherosclerosis
2021 StandoutNature
Hepatocellular carcinoma
2021 Standout
MicroRNAs in metabolism and metabolic disorders
2012
An Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa,Actaea racemosa) by the Natural Standard Research Collaboration
2014
Pathophysiology of NASH: Perspectives for a Targeted Treatment
2013
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance
2011
Global mapping of miRNA-target interactions in cattle (Bos taurus)
2017 StandoutNobel
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
2011 Nature
Innate Immunity and Inflammation in NAFLD/NASH
2016
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
2012
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
2020 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
2020
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Epigenetic Regulation of Kupffer Cell Function in Health and Disease
2021
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Real-Time Noninvasive Imaging of Fatty Acid Uptake in Vivo
2012 StandoutNobel
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Adipocytokines and hepatic fibrosis
2015
The cellular and signaling networks linking the immune system and metabolism in disease
2012
Inhibition of microRNA function by antimiR oligonucleotides
2012
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
2011
Chronic tissue inflammation and metabolic disease
2021
Acute-on-chronic Liver Failure
2016
Eyeballing cholesterol efflux and macrophage function in disease pathogenesis
2013
Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony
2019 Standout
Energy Metabolism in the Liver
2014 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Fatty liver and lipotoxicity
2009
Modeling Development and Disease with Organoids
2016 Standout
Long‐term therapeutic silencing of miR‐33 increases circulating triglyceride levels and hepatic lipid accumulation in mice
2014
Development of micro RNA therapeutics is coming of age
2014
MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
2015
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance
2012
MicroRNAs as Potential Regulators of Glutathione Peroxidases Expression and Their Role in Obesity and Related Pathologies
2018
Macrophage Polarization
2016 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Applying probiotics and prebiotics in new delivery formats – is the clinical evidence transferable?
2021
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
Kupffer Cell Metabolism and Function.
2015
Inflammatory mechanisms linking obesity and metabolic disease
2017
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Bioactives from Agri-Food Wastes: Present Insights and Future Challenges
2020 Standout
Phlorizin treatment attenuates obesity and related disorders through improving BAT thermogenesis
2016
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
2011
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia
2012
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials
2016
Gut Microbiota and Host Metabolism: From Proof of Concept to Therapeutic Intervention
2021
Identification of TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase
2014
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
2007
MicroRNA Regulation of Atherosclerosis
2016
Regulation of metabolism by the innate immune system
2015
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts
2011
MicroRNA regulation of mitochondrial and ER stress signaling pathways: implications for lipoprotein metabolism in metabolic syndrome
2014
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
2012
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity
2012
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
2020
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low - Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db / db Mice
2014
Works of Nicolas Lanthier being referenced
Kupffer Cells Influence Parenchymal Invasion and Phenotypic Orientation, but Not the Proliferation, of Liver Progenitor Cells in a Murine Model of Liver Injury
2011
Infliximab in the treatment of posterior uveitis in Behçet's disease
2005
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis
2009
Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
2010
Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution
2009
Adipose tissues as endocrine target organs
2014
Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial
2013
Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients
2020
Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?
2015
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome
2015
Kupffer cell activation is a causal factor for hepatic insulin resistance
2009
Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
2019
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet
2011